Emilio Galea (from September 2018)
Chronic wounds are an ever-growing challenge for clinicians and represent a huge burden on healthcare resources (Harding, 2002). They have been referred to as a silent epidemic that is affecting a large number of people in the world population (Gottrup, 2004). However, due to a better understanding of what makes a wound chronic, several new treatments that offer better outcomes for the patient and a broader choice for the clinician have been developed (Harding, 2002). A sterile, non-adherent, slough-trapping, poly-absorbent fibre dressing with the technologie lipido-colloïde (TLC) healing matrix to promote wound healing and enable pain-free dressing changes, which can be used for gentle desloughing, has been developed by Urgo. The slough-trapping fibres (poly-absorbent) have been shown to bind and trap the slough within the dressing, providing safe and effective desloughing (Kelly et al, 2013), while the silver lipido-colloid matrix in the antimicrobial version, has been established in its efficacy in the management of chronic wounds presenting with a risk of infection as demonstrated through previous randomised controlled trials … download PDF